Insulet to sell $65 million of senior notes

By Associated Press
June 10, 2008 | Comments (0)

Recs

0

Insulet Corp., which makes an insulin infusion system for diabetics, said Tuesday it is selling $65 million worth of convertible senior notes due 2013 to qualified institutional buyers.

The company said it also will grant initial buyers the option to purchase up to an added $10 million worth of notes to cover over-allotments, if any.

The notes will be convertible under certain circumstances into cash and stock. The interest rate, conversion rate and other terms will be negotiated.

Insulet said it will use proceeds from the offering to repay and terminate its outstanding term loan and for general corporate purposes.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 661360, ~/Articles/ArticleHandler.aspx, 12/2/2009 3:36:09 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Is Everybody Losing It in Finance's Nervous Breakdown?

By The Motley Fool

Is Everybody Losing It in Finance's Nervous Breakdown?

Related Tickers

12/1/2009 4:00 PM
PODD $12.07 Down -0.19 -1.55%
Insulet Corp CAPS Rating: *

Community: Investing Wiki

Term Of The Hour

Share buyback: A Share buyback occurs when a company repurchases some of its own stock either through purchasing shares on the open market or by buying shares directly from shareholders through a tender offer at a premium to current market price.

Want to learn more or edit this definition?
Click here to read more!